Concept of Materiovigilance and Importance in AYUSH
Keywords:
Materiovigilance
Abstract
The excerpt of this paper was read as a part of invited lecture during the National Webinar on Pharmacovigilance of Ayurveda Sidhha Unani and Homeopathy (ASU & H) Drugs - AYUSHSURAKSHA 2020 through Online Zoom. It was organized by the Intermediary Pharmacovigilance Centre, National Institute of Unani Medicine, Bangalore and sponsored by the Ministry of AYUSH, Govt. of India, New Delhi on 16.9.2020.
References
1. John Autian & Wallace Guess (1973) The New Field of Plastics Toxicology - Methods and Results, CRC Critical Reviews in Toxicology, 2:1, 1-40
2. Heneghan C, Thompson M, Billingsley M, Cohen D. Medical-device recalls in the UK and the device-regulation process: Retrospective review of safety notices and alerts. BMJ Open. 2011;1:e000155
3. Hauser RG. Here we go again – Another failure of postmarketing device surveillance. N Engl J Med. 2012;366:873–5
4. McGee RG, Webster AC, Rogerson TE, Craig JC. Medical device regulation in Australia: Safe and effective? Med J Aust. 2012;196:256–60
5. Higson GR. Medical Device Safety: The Regulation of Medical Devices for Public Health. London: IOP Publishing; 2002
6. Mirel S, Colobatiu L, Fasniuc E, Boboia A, Gherman C, Mirel V, et al. Materiovigilance and medical devices. In: Vlad S, Ciupa R, editors. International Conference on Advancements of Medicine and Health Care through Technology, IFMBE Proceedings. Vol. 44. Cluj-Napoca, Romania: Springer, Cham; 2014.
7. Jefferys DB. The regulation of medical devices and the role of the medical devices agency. Br J Clin Pharmacol. 2001; 52:229–35.
8. Gupta P, Janodia MD, Jagadish PC, Udupa N. Medical device vigilance systems: India, US, UK, and Australia. Med Devices (Auckl) 2010;3:67–79
9. Chauhan P, Zarreen A, Iqubal M.K. Current Status of Materiovigilance Globally – An Utter Overview with clinical case perusal. International Journal of Pharmacy and Pharmaceutical Sciences 2019; 11 (10): 1-8
10. Radhadevi N, Balamuralidhara V, Pramod Kumar TM, Ravi V. Regulatory guidelines for medical devices in India: An overview. Asian J Pharm. 2012;6:10–7
11. Kumar P, Kalaiselvan V, Kaur I, Thota P, Singh GN. Materiovigilance programme of India (MVPI): A step towards patient safety for medical devices. Eur J Biomed Pharm Sci. 2016;12:497–501
12. Meher BR. Materiovigilance: An Indian perspective. Perspect Clin Res. 2018 Oct-Dec;9(4):175-178. doi: 10.4103/picr.PICR_26_18.
13. Gupta SK. Medical Device regulations: A current perspective. J Young Pharm. 2016;8:6–11.
14. Rahman SZ, Concept of Materiovigilance in Unani Medicine, Bangladesh Journal of Medical Science 2019; 18 (1): 5-6
2. Heneghan C, Thompson M, Billingsley M, Cohen D. Medical-device recalls in the UK and the device-regulation process: Retrospective review of safety notices and alerts. BMJ Open. 2011;1:e000155
3. Hauser RG. Here we go again – Another failure of postmarketing device surveillance. N Engl J Med. 2012;366:873–5
4. McGee RG, Webster AC, Rogerson TE, Craig JC. Medical device regulation in Australia: Safe and effective? Med J Aust. 2012;196:256–60
5. Higson GR. Medical Device Safety: The Regulation of Medical Devices for Public Health. London: IOP Publishing; 2002
6. Mirel S, Colobatiu L, Fasniuc E, Boboia A, Gherman C, Mirel V, et al. Materiovigilance and medical devices. In: Vlad S, Ciupa R, editors. International Conference on Advancements of Medicine and Health Care through Technology, IFMBE Proceedings. Vol. 44. Cluj-Napoca, Romania: Springer, Cham; 2014.
7. Jefferys DB. The regulation of medical devices and the role of the medical devices agency. Br J Clin Pharmacol. 2001; 52:229–35.
8. Gupta P, Janodia MD, Jagadish PC, Udupa N. Medical device vigilance systems: India, US, UK, and Australia. Med Devices (Auckl) 2010;3:67–79
9. Chauhan P, Zarreen A, Iqubal M.K. Current Status of Materiovigilance Globally – An Utter Overview with clinical case perusal. International Journal of Pharmacy and Pharmaceutical Sciences 2019; 11 (10): 1-8
10. Radhadevi N, Balamuralidhara V, Pramod Kumar TM, Ravi V. Regulatory guidelines for medical devices in India: An overview. Asian J Pharm. 2012;6:10–7
11. Kumar P, Kalaiselvan V, Kaur I, Thota P, Singh GN. Materiovigilance programme of India (MVPI): A step towards patient safety for medical devices. Eur J Biomed Pharm Sci. 2016;12:497–501
12. Meher BR. Materiovigilance: An Indian perspective. Perspect Clin Res. 2018 Oct-Dec;9(4):175-178. doi: 10.4103/picr.PICR_26_18.
13. Gupta SK. Medical Device regulations: A current perspective. J Young Pharm. 2016;8:6–11.
14. Rahman SZ, Concept of Materiovigilance in Unani Medicine, Bangladesh Journal of Medical Science 2019; 18 (1): 5-6
Published
2020-12-31
Section
SHORT COMMUNICATIONS
Copyright (c) 2020 Syed Ziaur Rahman
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
